Bilateral Sutureless Application of Human Dehydrated Amniotic Membrane with a Specialised Bandage Contact Lens for Moderate-to-Severe Dry Eye Disease: A Prospective Study with 1-Month Follow-Up

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Review. Ocular Surface. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Smith JA, Albeitz J, Begley C, et al. The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Article. Ocul Surf. 2007;5(2):93–107.
   PubMed Web of Science ®Google Scholar
• Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Review. Ocul Surf. 2017;15(3):334–365. doi:10.1016/j.jtos.2017.05.003
   PubMed Web of Science ®Google Scholar
• Bradley JL, Özer Stillman I, Pivneva I, Guerin A, Evans AM, Dana R. Dry eye disease ranking among common reasons for seeking eye care in a large US claims database. Clin Ophthalmol. 2019;13:225–232. doi:10.2147/opth.s188314
   PubMed Web of Science ®Google Scholar
• Yu J, Asche CV, Fairchild CJ. The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea. 2011;30(4):379–387. doi:10.1097/ICO.0b013e3181f7f363
   PubMed Web of Science ®Google Scholar
• Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Review. Ocul Surf. 2017;15(3):438–510. doi:10.1016/j.jtos.2017.05.011
   PubMed Web of Science ®Google Scholar
• De Paiva CS, Corrales RM, Villarreal AL, et al. Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye. Exper Eye Res. 2006;83(3):526–535. doi:10.1016/j.exer.2006.02.004
   PubMed Web of Science ®Google Scholar
• Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Article; Proceedings Paper. Invest Ophthalmol. 2000;41(6):1356–1363.
   Google Scholar
• Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine Article. Archives of Ophthalmology. 2002;120(3):330–337.
   PubMedGoogle Scholar
• Li DQ, Chen Z, Song XJ, Luo LH, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Article. Invest Ophthalmol. 2004;45(12):4302–4311. doi:10.1167/iovs.04-0299
   Google Scholar
• Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apoptosis of ocular surface cells in experimentally induced dry eye. Article. Invest Ophthalmol. 2003;44(1):124–129. doi:10.1167/iovs.02-0581
   Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Review. Ocul Surf. 2017;15(3):575–628. doi:10.1016/j.jtos.2017.05.006
   PubMed Web of Science ®Google Scholar
• Hopkinson A, Britchford ER, Sidney LE. Preparation of dried amniotic membrane for corneal repair. In: Ahearne M, editor. Corneal Regeneration Methods and Protocols. Springer protocols; 2020:143–157.
   Google Scholar
• Dua HS, Gomes JAP, King AJ, Maharajan VS. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004;49(1):51–77. doi:10.1016/j.survophthal.2003.10.004
   PubMed Web of Science ®Google Scholar
• Hao YX, Ma DHK, Hwang DG, Kim WS, Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea. 2000;19(3):348–352. doi:10.1097/00003226-200005000-00018
   PubMed Web of Science ®Google Scholar
• Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;14:2057–2072. doi:10.2147/OPTH.S208008
   PubMed Web of Science ®Google Scholar
• Sanders FWB, Huang J, Alió Del Barrio JL, Hamada S, McAlinden C. Amniotic membrane transplantation: structural and biological properties, tissue preparation, application and clinical indications. Eye. 2023. doi:10.1038/s41433-023-02777-5
   Web of Science ®Google Scholar
• McDonald MB, Sheha H, Tighe S, et al. Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study. Clin Ophthalmol. 2018;12:677–681. doi:10.2147/OPTH.S162203
   PubMed Web of Science ®Google Scholar
• Maqsood S, Elsawah K, Dhillon N, et al. Management of persistent corneal epithelial defects with human amniotic membrane-derived dry matrix. Clin Ophthalmol. 2021;15:2231–2238. doi:10.2147/opth.s299141
   PubMed Web of Science ®Google Scholar
• Lotfy NM, Al Rashidi S, Hagras SM. Clinical outcomes of vacuum-dehydrated amniotic membrane (Omnigen) mounted on contact lens (Omnilenz) in eyes with acute chemical eye injuries. Graefes Arch Clin Exp Ophthalmol. 2023;2023. doi:10.1007/s00417-023-06151-9
   Google Scholar
• Mollan SP, Homer V, Gates S, Brock K, Sinclair AJ. One eye or two: statistical considerations in ophthalmology with a focus on interventional clinical trials. J Neuroophthalmol. 2021;41:4.
   Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Review. Ocul Surf. 2017;15(3):539–574. doi:10.1016/j.jtos.2017.05.001
   PubMed Web of Science ®Google Scholar
• Allen CL, Clare G, Stewart EA, et al. Augmented dried versus cryopreserved amniotic membrane as an ocular surface dressing. PLoS One. 2013;8(10):e78441. doi:10.1371/journal.pone.0078441
   PubMed Web of Science ®Google Scholar
• Liu T, Zhai HL, Xu YY, et al. Amniotic membrane traps and induces apoptosis of inflammatory cells in ocular surface chemical burn. Mol Vision. 2012;18:220–225.
   Web of Science ®Google Scholar
• Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SCG. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. 2008;126(8):1059–1066. doi:10.1001/archopht.126.8.1059
   PubMedGoogle Scholar
• Kim JS, Kim JC, Na BK, Jeong JM, Song CY. Amniotic membrane patching promotes healing and inhibits proteinase activity on wound healing following acute corneal alkali burn. Exp Eye Res. 2000;70(3):329–337. doi:10.1006/exer.1999.0794
   PubMed Web of Science ®Google Scholar
• Teson M, Lopez-Miguel A, Neves H, Calonge M, Gonzalez-Garcia MJ, Gonzalez-Meijome JM. Influence of climate on clinical diagnostic dry eye tests: pilot study. Optometry Vision Sci. 2015;92(9):E284–E289. doi:10.1097/opx.0000000000000673
   PubMed Web of Science ®Google Scholar
• Guillon JP. Use of the tearscope plus and attachments in the routine examination of the marginal dry eye contact lens patient. Article; Proceedings Paper. Lacrimal Gland Tear Film Dry Eye Synd 2. 1998;438:859–867.
   Google Scholar
• Wu SQ, Hong JX, Tian LJ, Cui XH, Sun XH, Xu JJ. Assessment of bulbar redness with a newly developed keratograph. Optometry Vision Sci. 2015;92(8):892–899. doi:10.1097/opx.0000000000000643
   PubMed Web of Science ®Google Scholar
• Peterson RC, Wolffsohn JS, Fowler CW. Optimization of anterior eye fluorescein viewing. Article. Am J Ophthalmol. 2006;142(4):572–575. doi:10.1016/j.ajo.2006.04.062
   PubMed Web of Science ®Google Scholar
• Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640–650. doi:10.1097/00003226-200310000-00008
   PubMed Web of Science ®Google Scholar
• Korb DR, Herman JP, Finnemore VM, Greiner JV, Olson MC, Scaffidi RC. Lid wiper epitheliopathy and associated dry eye symptoms. Meeting Abstract. Invest Ophthalmol. 2004;45:U123–U123.
   Google Scholar
• Mimouni M, Trinh T, Sorkin N, et al. Sutureless dehydrated amniotic membrane for persistent epithelial defects. Euro J Ophthalmol. 2022;32(2):875–879. 11206721211011354. doi:10.1177/11206721211011354
   Web of Science ®Google Scholar
• Suri K, Kosker M, Raber IM, et al. Sutureless amniotic membrane prokera for ocular surface disorders: short-term results. Article. Eye. 2013;39(5):341–347. doi:10.1097/ICL.0b013e3182a2f8fa
   Web of Science ®Google Scholar
• Shanbhag SS, Chodosh J, Saeed HN. Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis. Ocul Surf. 2019;17(3):560–564. doi:10.1016/j.jtos.2019.03.001
   PubMed Web of Science ®Google Scholar
• Mahmood AH, Alharbi AS, Almanea BA, Alsaati AF. Sutureless Amniotic Membrane (ProKera (R)) and Intravenous Immunoglobulin in the Management of Ocular Complications of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Overlap. Cureus. 2021;13(8):e16989. doi:10.7759/cureus.16989
   PubMed Web of Science ®Google Scholar
• Mead OG, Tighe S, Tseng SCG. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis. Taiwan J Ophthalmol. 2020;10(1):13–21. doi:10.4103/tjo.tjo_5_20
   PubMedGoogle Scholar
• Sheha H, Liang LY, Li JJ, Tseng SCG. Sutureless amniotic membrane transplantation for severe bacterial keratitis. Cornea. 2009;28(10):1118–1123. doi:10.1097/ICO.0b013e3181a2abad
   PubMed Web of Science ®Google Scholar
• Kheirkhah A, Casas V, Raju VK, Tseng SCG. Sutureless amniotic membrane transplantation for partial limbal stem cell deficiency. Am J Ophthalmol. 2008;145(5):787–794. doi:10.1016/j.ajo.2008.01.009
   PubMed Web of Science ®Google Scholar
• Morkin MI, Hamrah P. Efficacy of self-retained cryopreserved amniotic membrane for treatment of neuropathic corneal pain. Ocul Surf. 2018;16(1):132–138. doi:10.1016/j.jtos.2017.10.003
   PubMed Web of Science ®Google Scholar
• McDonald M, Janik SB, Bowden FW, et al. Association of treatment duration and clinical outcomes in dry eye treatment with sutureless cryopreserved amniotic membrane. Clin Ophthalmol. 2023;17:2697–2703. doi:10.2147/opth.s423040
   PubMed Web of Science ®Google Scholar
• Mehta A, Pradhan S, Figueiredo F. Low temperature vacuum-dehydrated amnion membrane (Omnigen) - Case series for the treatment of ocular surface burn and related complications at a tertiary eye unit in the UK. Invest Ophthalmol Visual Sci. 2021;62(8):1258.
   Web of Science ®Google Scholar
• Cheng AMS, Zhao D, Chen R, et al. Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf. 2016;14(1):56–63.
   PubMed Web of Science ®Google Scholar
• Cheng AMS, Tighe S, Sheha H, Tseng SCG. Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease. Int Ophthalmol. 2018;38(5):2219–2222. doi:10.1007/s10792-017-0708-y
   PubMed Web of Science ®Google Scholar
• John T, Tighe S, Sheha H, et al. Corneal nerve regeneration after self-retained cryopreserved amniotic membrane in dry eye disease. J Ophthalmol. 2017:20176404918. doi:10.1155/2017/6404918
   Web of Science ®Google Scholar
• Craig JP, Muntz A, Wang MTM, et al. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: a six-month multicentre, double-masked randomised controlled trial. Ocul Surf. 2021;20:62–69. doi:10.1016/j.jtos.2020.12.006
   PubMed Web of Science ®Google Scholar
• Paolin A, Cogliati E, Trojan D, et al. Amniotic membranes in ophthalmology: long term data on transplantation outcomes. Cell Tissue Bank. 2016;17(1):51–58. doi:10.1007/s10561-015-9520-y
   PubMed Web of Science ®Google Scholar
• Ijiri S, Kobayashi A, Sugiyama K, Tseng SCG. Evaluation of visual acuity and color vision in normal human eyes with a sutureless temporary amniotic membrane patch. Am J Ophthalmol. 2007;144(6):938–942. doi:10.1016/j.ajo.2007.08.003
   PubMed Web of Science ®Google Scholar
• Hopkinson A, McIntosh RS, Shanmuganathan V, Tighe PJ, Dua HS. Proteomic analysis of amniotic membrane prepared for human transplantation: characterization of proteins and clinical implications. J Proteome Res. 2006;5(9):2226–2235. doi:10.1021/pr050425q
   PubMed Web of Science ®Google Scholar
• Hopkinson A, McIntosh RS, Tighe PJ, James DK, Dua HS. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-beta content. Invest Ophthalmol Vis Sci. 2006;47(10):4316–4322. doi:10.1167/iovs.05-1415
   PubMed Web of Science ®Google Scholar
• Sánchez-González J-M, López-Izquierdo I, Gargallo-Martínez B, De-Hita-Cantalejo C, Bautista-Llamas M-J. Bandage contact lens use after photorefractive keratectomy. J Cataract Refract Surg. 2019;45:8.
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Ghimire D, Basu S, Agrawal V, Jacobs DS, Shanbhag SS. Contact lenses in dry eye disease and associated ocular surface disorders. Indian J Ophthalmol. 2023;71(4):1142–1153. doi:10.4103/ijo.ijo_2778_22
   PubMed Web of Science ®Google Scholar
• Wu X, Ma Y, Chen X, et al. Efficacy of bandage contact lens for the management of dry eye disease after cataract surgery. Int Ophthalmol. 2021;41(4):1403–1413. doi:10.1007/s10792-021-01692-6
   PubMed Web of Science ®Google Scholar
• Tavakoli A, Flanagan JL. Dry eye disease: an (in)convenient truth. Clin Exp Optometry. 2022;105(2):222–229. doi:10.1080/08164622.2021.1945410
   PubMed Web of Science ®Google Scholar
• Voigt J. Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndrome. Cost Eff Resour Allocation. 2020;18(1):56. doi:10.1186/s12962-020-00252-6
   PubMed Web of Science ®Google Scholar